Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension

NCT01788358 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

508

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)
DRUG: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)
DRUG: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)
DRUG: Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)

Sponsor

Bayer